Back
Innoviva Vs. NovoCure Industry Stock Comparison
Buy
56
INVA
Innoviva
Last Price:
18.57
Seasonality Move:
3.4%
Buy
75
NVCR
NovoCure
Last Price:
33.40
Seasonality Move:
-5.24%
Buy
56
Innoviva (INVA)
is a Buy
Is Innoviva a Buy, Sell or Hold?
- The current Innoviva [INVA] share price is $18.58. The Score for INVA is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
- INVA is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
75
NovoCure (NVCR)
is a Buy
Is NovoCure a Buy, Sell or Hold?
- The current NovoCure [NVCR] share price is $33.41. The Score for NVCR is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
- NVCR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
INVA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.2 | Sell |
Relative Strength Index (14 RSI): | 35.11 | Sell |
Chaikin Money Flow: | 322550 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (18.73 - 19.65) | Sell |
Bollinger Bands (100): | (18.66 - 19.78) | Sell |
NVCR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 3.78 | Buy |
Relative Strength Index (14 RSI): | 75.34 | Buy |
Chaikin Money Flow: | 1118573 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (16.36 - 28.56) | Buy |
Bollinger Bands (100): | (14.7 - 22.78) | Buy |
INVA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 18.87 | Sell |
20-day SMA: | 18.99 | Sell |
50-day SMA: | 19.47 | Sell |
200-day SMA: | 17.42 | Buy |
8-day EMA: | 18.83 | Sell |
20-day EMA: | 19.04 | Sell |
50-day EMA: | 19.2 | Sell |
200-day EMA: | 17.8 | Buy |
NVCR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 29.6 | Buy |
20-day SMA: | 23.68 | Buy |
50-day SMA: | 19.33 | Buy |
200-day SMA: | 17.9 | Buy |
8-day EMA: | 29.53 | Buy |
20-day EMA: | 25.45 | Buy |
50-day EMA: | 21.38 | Buy |
200-day EMA: | 19.88 | Buy |
Innoviva Earnings Growth & INVA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.25 per share, and an increase next year of $1.29 per share.
NovoCure Earnings Growth & NVCR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.71 per share, and a decrease next year of $0.31 per share.
Innoviva Technical Analysis
Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
NovoCure Technical Analysis
Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |